ArticleJournal of orthopaedic translation2026
A novel non-invasive approach monitoring skeletal stem cell function through
Article in Journal of orthopaedic translation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From local tissue repair to systemic precision orthopaedics: recent advances in musculoskeletal regeneration and translational medicine.Journal of orthopaedic translation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fracture nonunion remains a major clinical challenge and is closely associated with dysfunction of osteogenic-lineage cells and their progenitors, skeletal stem cells (SSCs). However, conventional clinical approaches lack the specificity required to assess SSC functional status Methods: We first integrated RNA sequencing with FDA-approved radiotracers, to demonstrate Results: By integrating SSC RNA sequencing with FDA-approved or radiotracers in III/IV phase clinical trials, we identified CXCR4 as a promising diagnostic target and evaluated SSC activity using Conclusion: Together, these findings establish CXCR4-targeted Translational potential of this article: This study facilitates the translation of fundamental skeletal stem cell (SSC) biology into clinical decision-making by repurposing the CXCR4-targeting radiotracer
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.